gracecastuc-013_lung_what should we do for a "mixed response" to lung cancer treatment?
Published 11 years ago • 71 plays • Length 5:09Download video MP4
Download video MP3
Similar videos
-
5:11
gracecastuc-015_lung_what is the biology of a mixed response in lung cancer?
-
6:11
gracecastuc-012_lung_the more you seek, the more you find
-
5:42
gracecastuc-006 - which patients with advanced lung cancer should potentially receive local therapy?
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
1:39
grace targeted therapies lung cancer 2021 - treatment after crizotinib in ros1 lung cancer
-
1:15
gracecastuc-054_lung_wakelee: my approach to repeat biopsies for adv. nsclc with insufficient tissue
-
31:37
targeted therapies in lung cancer patient forum: exercise for lung cancer patients
-
4:20
gracecastuc-002 - how should we treat locally advanced non-small cell lung cancer?
-
2:08
grace targeted therapies lung cancer 2021 - approved therapy for a cdkn2a secondary mutation?
-
3:40
platinum-based chemo doublets: backbone for nsclc treatment
-
4:46
lung cancer video library - "consolidation" radiation after a good response to 1st line.
-
6:40:28
full video ondemand -targeted therapies patient forum 2022 - for those living with lung cancer
-
1:57
alk nsclc: what does it mean? - 2022 program: targeted therapies forum
-
9:49
gracecast-001_lung-cancer_first line chemo for advanced nscl
-
13:05
gracecast-009_lung-cancer_the abc's of bac
-
4:31
grace targeted therapies lung cancer 2021 -recommended 2nd line & timing, stage 3 ros-1 lung cancer?
-
4:40
ntrk nsclc: treatment options and side effects - targeted therapies in lung cancer 2023
-
1:47
alk rearrangements: what are they, and who has them?
-
8:35
asco lung cancer roundtable - nsclc - the cityscape trial: anti tigit & immune checkpoint inhibitor